Share on StockTwits

Varian Medical Systems (NYSE:VAR) SVP John W. Kuo 582 shares of the stock on the open market in a transaction that occurred on Wednesday, July 9th. Following the completion of the , the senior vice president now directly owns 14,061 shares in the company, valued at approximately $1,195,185. The was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Varian Medical Systems (NYSE:VAR) traded down 0.14% on Friday, hitting $85.14. The stock had a trading volume of 540,552 shares. Varian Medical Systems has a one year low of $69.02 and a one year high of $86.60. The stock has a 50-day moving average of $83.11 and a 200-day moving average of $82.00. The company has a market cap of $8.850 billion and a price-to-earnings ratio of 21.88.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.01. The company had revenue of $779.00 million for the quarter, compared to the consensus estimate of $772.84 million. During the same quarter in the previous year, the company posted $1.04 earnings per share. The company’s revenue for the quarter was up 1.4% on a year-over-year basis. On average, analysts predict that Varian Medical Systems will post $4.30 earnings per share for the current fiscal year.

VAR has been the subject of a number of recent research reports. Analysts at ISI Group initiated coverage on shares of Varian Medical Systems in a research note on Monday, June 30th. They set a “neutral” rating and a $90.00 price target on the stock. Separately, analysts at Morgan Stanley reiterated an “underweight” rating on shares of Varian Medical Systems in a research note on Wednesday, May 7th. They now have a $76.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note on Friday, April 25th. They now have a $83.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $84.88.

Varian Medical Systems, Inc, is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.